Exact Mass: 507.17876040000004

Exact Mass Matches: 507.17876040000004

Found 81 metabolites which its exact mass value is equals to given mass value 507.17876040000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Naamidine F

Naamidine F

C25H25N5O7 (507.17539)


   

C24H29NO11

C24H29NO11 (507.17405240000005)


   

Ala Cys Glu Trp

(4S)-4-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Ala Cys Trp Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C22H29N5O7S (507.17876040000004)


   

Ala Glu Cys Trp

(4S)-4-[(2S)-2-aminopropanamido]-4-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Ala Glu Trp Cys

(4S)-4-[(2S)-2-aminopropanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Ala Trp Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]pentanedioic acid

C22H29N5O7S (507.17876040000004)


   

Ala Trp Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Cys Ala Glu Trp

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Cys Ala Trp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-(1H-indol-3-yl)propanamido]pentanedioic acid

C22H29N5O7S (507.17876040000004)


   

Cys Asp Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C17H29N7O9S (507.1747384)


   

Cys Asp Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanamido]butanedioic acid

C17H29N7O9S (507.1747384)


   

Cys Glu Ala Trp

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Cys Glu Trp Ala

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Cys Arg Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]-3-carboxypropanamido]butanedioic acid

C17H29N7O9S (507.1747384)


   

Cys Trp Ala Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]propanamido]pentanedioic acid

C22H29N5O7S (507.17876040000004)


   

Cys Trp Glu Ala

(4S)-4-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Asp Cys Asp Arg

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C17H29N7O9S (507.1747384)


   

Asp Cys Arg Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanamido]butanedioic acid

C17H29N7O9S (507.1747384)


   

Asp Asp Cys Arg

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]-5-carbamimidamidopentanoic acid

C17H29N7O9S (507.1747384)


   

Asp Asp Arg Cys

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-4-carbamimidamido-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C17H29N7O9S (507.1747384)


   

Asp Gly Met Trp

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}methyl)carbamoyl]propanoic acid

C22H29N5O7S (507.17876040000004)


   

Asp Gly Trp Met

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C22H29N5O7S (507.17876040000004)


   

Asp Met Gly Trp

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Asp Met Trp Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Asp Arg Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]butanedioic acid

C17H29N7O9S (507.1747384)


   

Asp Arg Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C17H29N7O9S (507.1747384)


   

Asp Trp Gly Met

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C22H29N5O7S (507.17876040000004)


   

Asp Trp Met Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-3-(methylsulfanyl)propyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Glu Ala Cys Trp

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Glu Ala Trp Cys

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Glu Cys Ala Trp

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Glu Cys Trp Ala

(4S)-4-amino-4-{[(1R)-1-{[(1S)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Glu Trp Ala Cys

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Glu Trp Cys Ala

(4S)-4-amino-4-{[(1S)-1-{[(1R)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Gly Asp Met Trp

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Gly Asp Trp Met

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C22H29N5O7S (507.17876040000004)


   

Gly Met Asp Trp

(3S)-3-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Gly Met Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C22H29N5O7S (507.17876040000004)


   

Gly Trp Asp Met

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]-4-(methylsulfanyl)butanoic acid

C22H29N5O7S (507.17876040000004)


   

Gly Trp Met Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]butanedioic acid

C22H29N5O7S (507.17876040000004)


   

Met Asp Gly Trp

(3S)-3-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-[({[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C22H29N5O7S (507.17876040000004)


   

Met Asp Trp Gly

(3S)-3-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Met Gly Asp Trp

(3S)-3-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Met Gly Trp Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-indol-3-yl)propanamido]butanedioic acid

C22H29N5O7S (507.17876040000004)


   

Met Trp Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C22H29N5O7S (507.17876040000004)


   

Met Trp Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]acetamido}butanedioic acid

C22H29N5O7S (507.17876040000004)


   

Arg Cys Asp Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-sulfanylpropanamido]-3-carboxypropanamido]butanedioic acid

C17H29N7O9S (507.1747384)


   

Arg Asp Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-sulfanylpropanamido]butanedioic acid

C17H29N7O9S (507.1747384)


   

Arg Asp Asp Cys

(3S)-3-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C17H29N7O9S (507.1747384)


   

Trp Ala Cys Glu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-3-sulfanylpropanamido]pentanedioic acid

C22H29N5O7S (507.17876040000004)


   

Trp Ala Glu Cys

(4S)-4-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Cys Ala Glu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]propanamido]pentanedioic acid

C22H29N5O7S (507.17876040000004)


   

Trp Cys Glu Ala

(4S)-4-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-4-{[(1S)-1-carboxyethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Asp Gly Met

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-carboxypropanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Asp Met Gly

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-3-(methylsulfanyl)propyl]carbamoyl}propanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Glu Ala Cys

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Glu Cys Ala

(4S)-4-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-{[(1R)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}butanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Gly Asp Met

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-carboxypropanamido]-4-(methylsulfanyl)butanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Gly Met Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-4-(methylsulfanyl)butanamido]butanedioic acid

C22H29N5O7S (507.17876040000004)


   

Trp Met Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C22H29N5O7S (507.17876040000004)


   

Trp Met Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]acetamido}butanedioic acid

C22H29N5O7S (507.17876040000004)


   

Quinacrine Dihydrochloride Dihydrate

Quinacrine Dihydrochloride Dihydrate

C23H36Cl3N3O3 (507.1822116000001)


   

(S,E)-ETHYL 7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-5-HYDROXY-3-OXOHEPT-6-ENOATE

(S,E)-ETHYL 7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-(N-METHYLMETHYLSULFONAMIDO)PYRIMIDIN-5-YL)-5-HYDROXY-3-OXOHEPT-6-ENOATE

C24H30FN3O6S (507.18392520000003)


   

CLEBOPRIDE malATE

Clebopride (malate)

C24H30ClN3O7 (507.17721800000004)


C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist Clebopride malate is a dopamine antagonist used in the study of functional gastrointestinal disorders.

   

Umeclidinium Bromide

Umeclidinium (bromide)

C29H34BrNO2 (507.17727640000004)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Umeclidinium bromide is a novel mAChR antagonist. The affinity (Ki) of Umeclidinium bromide for the cloned human M1-M5 mAChRs ranges from 0.05 to 0.16 nM.

   

(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate

(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate

C25H31O11- (507.18662759999995)


   

Lonijaposide G

Lonijaposide G

C24H29NO11 (507.17405240000005)


A natural product found in Lonicera japonica.

   

Lonijaposide F

Lonijaposide F

C24H29NO11 (507.17405240000005)


A natural product found in Lonicera japonica.

   

Lonijaposide L

Lonijaposide L

C24H29NO11 (507.17405240000005)


A natural product found in Lonicera japonica.

   

gibberellin A3 O-beta-D-glucoside(1-)

gibberellin A3 O-beta-D-glucoside(1-)

C25H31O11- (507.18662759999995)


   

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide

C24H33N3O5S2 (507.18615280000006)


   

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide

C24H33N3O5S2 (507.18615280000006)


   

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide

N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide

C24H33N3O5S2 (507.18615280000006)


   

(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-thiazolylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

(1R)-N-(4-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-1-(2-thiazolylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C26H26FN5O3S (507.1740298000001)


   

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide

N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-thiophenesulfonamide

C24H33N3O5S2 (507.18615280000006)


   

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide

N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide

C24H33N3O5S2 (507.18615280000006)


   

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide

N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide

C24H33N3O5S2 (507.18615280000006)


   

Ibiglustat (succinate)

Ibiglustat (succinate)

C24H30FN3O6S (507.18392520000003)


Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease[1][2].

   

5-({2-[(2-hydroxy-1-methyl-5-oxoimidazol-4-ylidene)amino]-5-[(4-methoxyphenyl)methyl]-3-methylimidazol-4-yl}methyl)-2,3-dimethoxycyclohexa-2,5-diene-1,4-dione

5-({2-[(2-hydroxy-1-methyl-5-oxoimidazol-4-ylidene)amino]-5-[(4-methoxyphenyl)methyl]-3-methylimidazol-4-yl}methyl)-2,3-dimethoxycyclohexa-2,5-diene-1,4-dione

C25H25N5O7 (507.17539)


   

3-carboxy-5-[(1e)-2-[(2s,3r,4s)-5-carboxylato-3-ethenyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]ethenyl]-1-ethylpyridin-1-ium

3-carboxy-5-[(1e)-2-[(2s,3r,4s)-5-carboxylato-3-ethenyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]ethenyl]-1-ethylpyridin-1-ium

C24H29NO11 (507.17405240000005)